UK and France launch AI partnership to transform health research
Healthcare transformation advances as UK and France invest in AI.
The United Kingdom and France have launched a science and technology partnership focused on applying AI, advanced imaging, and data science to major healthcare challenges, including women’s health, infectious diseases, and antimicrobial resistance.
The UK-France Strategic Biomedical Alliance in Health and AI will bring together institutions including the University of Oxford, Université Paris Cité, Institut Pasteur, Diamond Light Source, and Synchrotron SOLEIL. The partnership aims to make it easier for British and French institutions to cooperate on biomedical research, share expertise, and develop joint projects and funding bids.
The initiative will support research into conditions such as endometriosis and childbirth-related complications, while also improving the detection and treatment of infectious diseases, including tuberculosis, malaria, emerging viruses, and drug-resistant bacteria. Researchers will use AI, data science, and advanced imaging technologies to support earlier diagnoses, more personalised care, and improved preparedness for future health threats.
Alongside the biomedical partnership, the UK and France are strengthening cooperation in high-performance computing. Nearly £900,000 in UK government funding has been committed to a partnership between the Bristol Centre for Supercomputing, which hosts Isambard-AI, and France’s national high-performance computing body GENCI.
The collaboration is expected to give researchers at both centres access to advanced computing resources and support AI research and scientific discovery across multiple fields.
The UK will also contribute £300,000, matched by €330,000 from the French government, to support early-career researchers living and working in both countries. The mobility funding is intended to strengthen research collaboration, including on Horizon Europe projects.
Imperial College London and the French National Centre for Scientific Research will also sign a separate agreement to collaborate on metabolism research, covering health challenges including heart disease, cancer, and neurodegenerative disorders.
Why does it matter?
The partnership shows how AI cooperation is increasingly being embedded in biomedical research, advanced imaging, and high-performance computing infrastructure. By linking health research with supercomputing capacity and researcher mobility, the UK and France are treating AI as part of a broader science diplomacy and innovation agenda, rather than only as a standalone technology policy issue.
Would you like to learn more about AI, tech and digital diplomacy? If so, ask our Diplo chatbot!